Tag: AAA
EVES 2024 Summit audience encouraged to “master all techniques” for AAA...
During a presentation at the Egyptian Vascular and Endovascular Society (EVES) 2024 Summit (30 October–2 November, Cairo, Egypt) on managing abdominal aortic aneurysm (AAA),...
Use of AI in endoleak detection deemed “feasible” with “potentially significant”...
A recently published retrospective study has shown that a deep learning model based on non-contrast computed tomography (CT) can detect endoleak after endovascular aneurysm...
Are we overtreating aortic aneurysms in the elderly?
A large meta-analysis of elective endovascular aneurysm repair (EVAR) outcomes by age has shown that three-to-five-year survival is very low in octogenarians, prompting researchers...
Vascular News’ top 10 most popular stories of August 2024
Commencement of the CALCIO trial—designed to collect real-world data on the use of intravascular lithotripsy (IVL) with the Shockwave Medical IVL system in patients...
Physician-modified endografts “safe and effective” for thoracoabdominal and complex AAA repair
Researchers have reported a 94% technical success rate among other key findings from a recent international, multicentre, single-arm cohort study of physician-modified endografts (PMEGs)...
Machine learning-based model could aid in determining EVAR suitability
Researchers at the University Medical Center Groningen (Groningen, The Netherlands) and the University of Twente (Enschede, The Netherlands) have developed a prediction model that...
Towards a clinically applicable prediction model for aneurysm shrinkage after EVAR
Michel Reijnen and Rianne van Rijswijk (both Rijnstate Hospital, Arnhem, The Netherlands) write about a new consortium focused on sac regression after endovascular aneurysm...
Endoron Medical raises US$10 million in Series A funding
Endoron Medical has announced the successful closing of its US$10 million Series A funding round. The round was led by Sofinnova Partners, with significant...
Artivion amends agreements with Endospan
Artivion recently announced it has amended its credit facility and option purchase agreements with Endospan, developer of the Nexus stent graft system. In 2019,...
Terumo Aortic announces the first commercial implant of Fenestrated TREO in...
This advertorial is sponsored by Terumo Aortic.
On 9 April 2024, a significant milestone was achieved as Terumo Aortic introduced the first implantation of the...
Shape Memory Medical announces first patient treated in the AAA-SHAPE randomised...
Shape Memory Medical recently announced that the first patient has been treated in the AAA-SHAPE pivotal trial.
AAA-SHAPE (Abdominal aortic aneurysm sac healing and prevention...
Clinical data and experience point to safety and feasibility of Manta...
This advertorial, sponsored by Teleflex, is only available in selected countries and geographies.
Ozan Yazar is a vascular and endovascular surgeon with international training...
US FDA approves expanded indication for Gore Excluder conformable device
Gore has announced US Food and Drug Administration (FDA) approval of an expanded indication for the Gore Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis....
Nectero Medical announces completion of US$96 million Series D financing
Nectero Medical recently announced the closing of its US$96 million Series D financing round.
Financing was led by Norwest Venture Partners, with large investments...
“There are a lot of possibilities”: Deep learning in the vascular...
Eric Ducasse (University of Bordeaux, Bordeaux, France) spoke with Vascular News at this year’s Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany) on...
Vascular News’ top 10 most popular stories of February 2024
February's top 10 includes an update from the UK Medicines and Healthcare products Regulatory Agency (MHRA) on the use of paclitaxel-coated devices for peripheral...
Shape Memory Medical advances endovascular embolisation by completing $38 million in...
Shape Memory Medical has announced that it has completed $38 million in Series C financing, which has been led by Earlybird Venture Capital, along...
Type 2 endoleaks in AAA: What is their clinical relevance?
This advertorial, sponsored by Gore, is only available in selected countries and geographies.
Michel Reijnen (Arnhem, The Netherlands) discusses the clinical relevance of type...
Rijnstate Hospital at the forefront of international research into the treatment...
Rijnstate Hospital in Arnhem, The Netherlands, recently announced that the first patient has been enrolled in the HERCULES trial comparing endosuture aneurysm repair (ESAR)...
ESVS 2024 clinical practice guidelines on the management of abdominal aortoiliac...
The updated European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines for the care of patients with aneurysms of the abdominal aorta and...
Nectero Medical announces initiation of Phase II/III clinical trial of the...
Nectero Medical today announced initiation of a Phase II/III clinical trial (stAAAble) to investigate the safety and efficacy of the Nectero Endovascular Aneurysm Stabilisation...
Active sac management represents “step forward” for EVAR
"Despite significant technological improvements since its inception, endovascular repair of abdominal aortic aneurysms (AAAs) is still associated with some of the same problems we...
Peter Schneider
Peter Schneider (University of California San Francisco, San Francisco, USA) speaks to Vascular News about his life and career. Trained during the era of...
One-year results from AAA-SHAPE trial to be presented at VEITH 2023
Shape Memory Medical, developer of custom shape memory polymers for endovascular markets, announced that one-year data from the AAA-SHAPE safety trial will be presented...
Nectero Medical granted Breakthrough Therapy designation for the Nectero EAST system...
Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the Nectero Endovascular Aneurysm Stabilisation Treatment...
Vascular News 100 – November 2023 US Edition
In this issue:
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Forty five-year legacy of CX vascular education continues: The new CX...
Vascular News 100 – November 2023
In this issue:
Obituary: Roger M Greenhalgh 6th February 1941 – 6th October 2023
Forty five-year legacy of CX vascular education continues: The new...
Alcami supports Phase II/III trial supply of the Nectero EAST system
Alcami has welcomed the recent announcement by Nectero Medical that it has received clearance from the US Food and Drug Administration (FDA) of their...
Shape Memory Medical receives US FDA IDE approval to initiate head-to-head...
Shape Memory Medical recently announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) for the company to begin...
First US patient enrolled in SOCRATES short neck AAA trial
The first US patient has been treated as part of the SOCRATES trial (Short neck AAA randomised trial—ESAR and FEVAR), which compares the safety...
Postcode matters: Residing in areas of economic distress related to poor...
A new study in the Journal of Vascular Surgery (JVS) finds that a patient’s postcode is a crucial indicator for advanced stages of an...
New study reports positive performance of AI-powered assessment of biomarkers for...
The characterisation of aortic tissue by means of three key biomechanics-based biomarkers bundled into a compound Regional Areas of Weakness (RAW) Map showed “very...
Nectero Medical receives FDA clearance of IND application to initiate Phase...
Nectero Medical today announced that the US Food and Drug Administration (FDA) has granted investigational new drug (IND) clearance for the company to initiate...
Shape memory polymer: “Another step down the road” toward active aneurysm...
“There is an increasing awareness that we need to get aneurysm sacs to regress after endovascular aneurysm repair ,” Andrew Holden (Auckland, New Zealand)...
Vascular News’ top 10 most popular stories of June 2023
Highlights from this year’s Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM 2023; 14–17 June, National Harbor, USA) feature prominently in June's top 10.
1. “Sonolysis...
Novel drug candidate for slowing AAA growth demonstrates safety in humans
The local delivery of a glucose-derived compound in small- and medium-sized abdominal aortic aneurysms (AAAs) has been deemed safe, with “promising” early efficacy data...
Endologix announces 150th patient enrolled in JAGUAR randomised controlled trial
Endologix recently announced the completion of the 150th case in the JAGUAR study.
This randomised controlled trial is evaluating Endologix’s Alto abdominal stent graft...
Five-year results of the LEOPARD trial published in the Journal of...
Endologix has announced the online publication of the final five-year results of the LEOPARD trial in the Journal of Vascular Surgery (JVS). The study's...
Endurant stent graft proves efficacious and durable in ENGAGE 10-year data
A first-to-podium presentation at the 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK) saw Hence Verhagen (Erasmus Medical Center, Rotterdam, The Netherlands)...
CX 2023: Statins save lives after aortic repair regardless of dose
Statin treatment after aortic repair is associated with improved long-term survival, while dose does not matter. This was the key message from a first-to-podium...
Trusted together: AAA treatment with E-tegra and E-liac
This educational supplement, sponsored by Artivion, is only available in selected countries and geographies.
The E-liac stent graft system (Artivion/Jotec), according to the clinical...
Short neck AAAs: “Choosing what is best for the patient”
Navigating cases of abdominal aortic aneurysm (AAA) with short neck anatomy pose a serious challenge to vascular surgeons, but the list of potential options...
Study highlights need for “continuous comparative assessments” to guide endograft treatment...
A recent study comparing outcomes of endovascular aneurysm repair (EVAR) patients has reported no statistically significant differences in mortality or secondary rupture rates between...
Viz.ai receives FDA 510(k) clearance for abdominal aortic aneurysm AI algorithm
Viz.ai recently announced it has received US Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm...
Socioeconomic disparities in operation and survival rates for abdominal aortic aneurysm,...
A new study from the University of Sheffield, published in the British Journal of Surgery (BJS), has found clear evidence of socioeconomic disparities in...
Algorithm predicts females have higher risk for kidney damage after aneurysm...
When receiving treatment for abdominal aortic aneurysm (AAA), female patients have a higher risk for kidney damage after endovascular repair, a Michigan Medicine study...
Shockwave IVL: The last piece of the puzzle to overcome the...
This article forms part of an educational supplement sponsored by Shockwave Medical. Explore the full Compliance is Key series here.
Giacomo Isernia and Gioele Simonte...
Shape Memory Medical announces first patient treated in EMBO postmarket surveillance...
Shape Memory Medical has announced the first patient treated in Germany as part of the EMBO postmarket surveillance registry (EMBO-PMS), the company’s prospective, multicentre...
Iliac side branch devices a “gamechanger” in AAA treatment
NOTE: This video is ONLY available to watch in selected countries and geographies
Iliac side branch devices (ISBs) are “gamechangers in infrarenal therapy of...
Vascular News’ top 10 most popular stories of January 2023
January's top 10 highlights an individual patient data meta-analysis on the safety of carotid endarterectomy in the elderly and a new randomised trial on...
AAA screening: UK programme’s 10-year anniversary prompts renewed push for increasing...
The UK’s national abdominal aortic aneurysm (AAA) screening programme is fast approaching its 10th anniversary—a milestone that Akhtar Nasim (Sheffield Vascular Institute, Sheffield, Sheffield,...
ESVS AAA guidelines alert recommends “enhanced surveillance” in patients treated with...
In a newly released “focused update” to their 2019 recommendations, the European Society for Vascular Surgery (ESVS) abdominal aortic aneurysm (AAA) guidelines writing committee...
Viz.ai launches AI-powered Viz Vascular Suite
Viz.ai has announced the launch of Viz Vascular Suite—artificial intelligence (AI)-powered software enabling vascular care teams to automatically detect and triage care for suspected...
Markus Steinbauer
Despite his initial intention to become a transplant surgeon, Markus Steinbauer (Krankenhaus Barmherzige Brüder, Regensburg, Germany) recalls how the rise of endovascular techniques, and...
Endologix receives US FDA approval of PMA supplement for AFX2 system
Endologix recently announced that it has received US Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2...
CX Aortic Vienna: Evidence highlights the need to address disparities in...
Presentations and discussions at the CX Aortic Vienna 2022 Digital Edition (24–26 October) highlighted the fact that population screening for abdominal aortic aneurysm (AAA)...
Emergency EVAR protocol should be “first-line intervention” for the right patients
In a recently published study, the introduction of endovascular aneurysm repair (EVAR) into the management of ruptured abdominal aortic aneurysm (AAA) decreased the 30-day...
Fully automated software using artificial intelligence could become a “crucial adjunct”...
A software named PRAEVAorta (Nurea), using artificial intelligence (AI), has the potential to enable a fast, reproducible, and fully automated analysis of abdominal aortic...
WARRIORS randomised trial aims to examine early EVAR in women
This month a multinational collaboration of researchers received endorsement from the Global Cardiovascular Research Funders Forum (GCRFF) Multinational Clinical Trials Initiative for the WARRIORS...
Vascular News’ top 10 most popular stories of August 2022
The establishment of the first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in lower extremity and arterial and venous interventions, results...
Shape Memory Medical completes enrolment in the AAA-SHAPE early feasibility study
Shape Memory Medical has announced the completion of patient enrolment in AAA-SHAPE, the company’s prospective, multicentre early feasibility safety study of the Impede-FX RapidFill...
Community-based exercise programme reduces AAA morbidity and mortality in randomised trial
Results of a randomised controlled trial (RCT) point to the beneficial effects of a community-based exercise programme on outcomes in patients with an abdominal...
Endologix receives CE mark certification under EU-MDR for AFX2 endovascular AAA...
Endologix recently announced that is has received CE mark certification under the new EU Medical Devices Regulation (EU-MDR) for its AFX2 endovascular abdominal aortic...
Shape Memory Polymer addresses an “unmet need” for EVAR
Andrew Holden (Auckland, New Zealand) and Michel Reijnen (Arnhem, The Netherlands) discuss Shape Memory Polymer (Shape Memory Medical)—a porous scaffold that, according to Holden,...
Shape Memory Medical celebrates treatment of 1,500th patient
Shape Memory Medical announced today that its 1,500th patient has been treated, marking a significant milestone for the company’s portfolio of shape memory polymer...
Female sex is associated with reintervention and mortality following elective EVAR
Women are more likely to die within five years of having elective surgery to repair an abdominal aortic aneurysm (AAA) or need repeat surgery,...
Artificial intelligence can predict risk of complications after endovascular aneurysm repair
Artificial intelligence (AI) models can be developed to predict the risk of postoperative complications after endovascular aneurysm repair (EVAR) with “high accuracy,” research presented...
Less frequent post-EVAR surveillance might be safe in some patient groups,...
Results from the multicentre, retrospective ODYSSEUS study carried out in The Netherlands suggest that less frequent surveillance after endovascular aneurysm repair (EVAR) may be...
Stable and reliable: A vascular surgeon’s perspective on the benefits of...
This advertorial is sponsored by Shape Memory Medical.
Smart Polymer is a new shape memory polymer technology, available to endovascular specialists, that is incorporated into...
Cancer patients face greater risks from abdominal aortic aneurysm repair
Elective abdominal aortic aneurysm (AAA) repair in patients with a cancer diagnosis is associated with several poor postoperative outcomes according to a newly published...
FDA advisory panel issues recommendations on lifelong surveillance and long-term postmarket...
The US Food and Drug Administration (FDA) recently announced it has issued a letter to healthcare providers emphasising the importance of lifelong surveillance, including...
Study validates SVS abdominal aortic aneurysm volume recommendations
A multicentre, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA) outcomes when surgeon volume is greater than seven cases yearly and performed...
Vascular News’ top 10 most popular stories of January 2022
Breakthrough designation for a new drug-eluting stent from Cook Medical, a meta-analysis on the safety of expedited carotid artery surgery vs. expedited stenting after...
FDA issues updated safety communication on use of Endologix AFX endovascular...
Today, the US Food and Drug Administration (FDA) issued an updated safety communication on the use of Endologix AFX endovascular grafts. This update includes...
VEITH 2021: Researchers present ex vivo demonstration of fluoroscopy-free complex AAA...
“I think this represents the beginning of the end of an era where we have to use lead to perform these procedures.” Those were...
VEITH 2021: Two-year follow-up data from EVAS2 IDE study delivered
The confirmatory EVAS2 clinical study to evaluate the safety and effectiveness of the Nellix endovascular aneurysm sealing system (EVAS; Endologix) for the treatment of...
Recruitment passes halfway point for FEVAR study with Bentley bridging stent
Bentley has announced that on-label use of the company's BeGraft peripheral balloon-expandable covered stent in complex aortic aneurysms is a step closer with more...
Endologix names Matthew Thompson president and CEO
Endologix has announced the appointment of Matthew Thompson as president and chief executive officer. Thompson will also join Endologix’s board of directors. Richard Mott,...
Julie A Freischlag becomes president of American College of Surgeons
Newly-installed American College of Surgeons (ACS) president Julie A Freischlag (Wake Forest Baptist Health, Wake Forest School of Medicine, Winston-Salem and Atrium Health Enterprise,...
Terumo Aortic announces PMDA approval and first commercial implant of Treo...
Following the recent approval by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) of the Treo abdominal aortic stent graft system for sale in...
Vascular News’ top 10 most popular stories of September 2021
September's top 10 features five-year ACST-2 results, a new tool to assess amputation risk following popliteal vascular injury, and an interview highlighting the questions...
Endologix initiates randomised study of Alto abdominal stent graft system
Endologix today announced that the first patient has been enrolled in the company’s JAGUAR study to compare outcomes for the Alto abdominal stent graft...
Nectero Medical completes US$19.5 million Series C financing
Nectero Medical Inc has announced the closing of its US$19.5 million Series C financing round, led by new investor Boston Scientific Corporation. Proceeds will support...
Modern AAA metrics support expanding current screening guidelines
Results of a database review of more than 500,000 abdominal aortic aneurysm (AAA) repairs revealed the majority of patients treated for rupture did not...
First patient enrolled in Shape Memory Medical’s AAA-SHAPE Netherlands study
Shape Memory Medical has announced the initiation of AAA-SHAPE Netherlands, the company’s prospective, multicentre early feasibility study of the Impede-FX RapidFill device when used...
Vascular News’ top 10 most popular stories of July 2021
Updated Society for Vascular Surgery (SVS) clinical practice guidelines on extracranial cerebrovascular disease management and a new meta-analysis on paclitaxel in peripheral arterial disease...
Performance of commonly-used risk scores for AAA repair varies, study finds
As regards in-hospital mortality for abdominal aortic aneurysm (AAA) repair, researchers have found that “not all risk scores are created equal”. Livia E V...
Endologix receives FDA Breakthrough Device designation for ChEVAS system
Endologix today announced the company’s ChEVAS (chimney endovascular aneurysm sealing) system has been granted a Breakthrough Device designation from the US Food and Drug...
Translumbar embolisation for type II endoleak “safe and effective” following EVAR,...
Writing in an article published online in the Journal of Vascular Surgery (JVS), John F Charitable, Neal Cayne (both NYU Langone Health, New York,...
Viz.ai and Avicenna.AI partner to launch AI-driven intelligent care coordination for...
Viz.ai has partnered with Avicenna.AI to enable intelligent care coordination and improve patient triage of patients suffering from pulmonary embolism (PE) and aortic disease.
Avicenna.AI’s US...
Vascular News’ top 10 most popular stories of June 2021
New data from Philips' TOBA II below-the-knee (BTK) clinical trial, physicians' call for the AMPREDICT decision support tool to be applied in clinical practice,...
“Significant variations in the interpretation of the ESVS AAA guidelines” remain...
In a study of over 100,000 intact abdominal aortic aneurysm (AAA) repairs, an increase in the proportion of patients undergoing endovascular aneurysm repair (EVAR)...
Large study shows continued and quickening decline in AAA mortality
According to a new, population-based analysis, abdominal aortic aneurysm (AAA) mortality has continued to decline and “at a faster rate than ever” in the...
Concern for outgrowing EVAR suitability in small AAA “unwarranted” within two-year...
“The majority of patients eligible for EVAR when entering a surveillance programme for small AAA remain eligible after two years,” write Annalise...
Endologix announces launch of Alto abdominal stent graft system in Canada...
Endologix today announced the first implant of its Alto abdominal stent graft in Canada following recent approval from Health Canada. Alto was also recently...
GORE® ACTIVE CONTROL System: “A system for the masses”
NOTE: This video is ONLY available to watch in selected countries and geographies
Robert Rhee (New York, USA) moderates a Charing Cross 2021 webinar–A...
Independent Vascular Services launches quality assurance service to unburden UK NAAASP
Independent Vascular Services (IVS) recently announced the launch of its new Corelab Remote Quality Assurance (QA) service for the UK National Abdominal Aortic Aneurysm...
Researchers propose systematic screening for thoracoabdominal aneurysms in patients with AAAs
Results of the French ACTA (Aortic concomitant thoracic and abdominal aneurysm) study “confirm that thoracic aortic aneurysms (TAAs) coexisting with abdominal aortic aneurysms (AAAs)...
Vascular News’ top 10 most popular stories of March 2021
Newly-published data on the benefits of a dedicated vascular limb salvage clinic, key product launches in the vascular access space, and evidence to suggest...
Study shows that dual screening for lung cancer and AAA could...
A single-centre, retrospective study reveals that approximately 11% of patients diagnosed with lung cancer concurrently have an abdominal aortic aneurysm (AAA). Researchers theorise dual...
Less than a quarter of aortic centres meet optimal open AAA...
In an assessment of open aortic surgery by the International Consortium of Vascular Registries (ICVR), 13–16 procedures per year predicted the most significant reduction...
UK AAA screening results show “considerable” local variation in proportion of...
The first detailed surgical results from the UK National Health Service (NHS) Abdominal Aortic Aneurysm Screening Programme (NAAASP) show that, over a seven-year period,...
Piur Imaging launches Remote Expert AI-based image analysis platform
Piur Imaging has launched its remote image analysis platform, called Piur Remote Expert, for research users. It is a solution to perform remote image...
Primary endpoint results from Treo pivotal study published
Following recent approval by the US Food and Drug Administration (FDA) of the Treo abdominal aortic stent graft system for the treatment of patients...
Philips introduces 3D ultrasound-based model for AAA surveillance
Royal Philips has introduced the Philips Abdominal Aortic Aneurysm (AAA) Model, providing physicians a more patient-friendly solution compared to the current standard of care for...
FDA approves Gore Excluder conformable AAA endoprosthesis with Active Control system
W L Gore & Associates (Gore) recently announced that the US Food and Drug Administration (FDA) has granted regulatory approval for the new Gore...
Study of patients undergoing AAA repair suggests screening guidelines may be...
A retrospective study analysing approximately 55,000 patients undergoing abdominal aortic aneurysm (AAA) repair suggests current screening guidelines may be inadequate in detecting a significant...
Patient reassurance and education needed to address drop in AAA surveillance...
In a survey conducted by St George’s Vascular Institute (London, UK) on the willingness of patients in South London to attend abdominal aortic aneurysm...
EVAR not costlier than open repair for most routine AAA repairs,...
A recent systematic evaluation of the costs of elective endovascular aneurysm repair (EVAR) and open infrarenal abdominal aortic aneurysm (AAA) repair implies cost equivalence....
Study identifies new genetic factors associated with AAA risk
The American Heart Association (AHA) recently announced the publication of a study identifying 14 new genes linked to an increased risk of abdominal aortic...
Shape Memory Medical announces first patient enrolment in AAA-SHAPE study
Shape Memory Medical has announced the initiation of AAA-SHAPE, the company’s prospective safety study of the Impede-FX embolisation plug devices when used for abdominal...
Analysis suggests reassessment of operative threshold for AAA repair during COVID-19
According to a recent analysis, the decision to delay operative repair of abdominal aortic aneurysm (AAA) should consider both patient age and local COVID-19...
MicroPort’s Minos and Hercules stent grafts now CE marked and available...
According to a recent press release, MicroPort’s Minos ultra-low abdominal aortic aneurysm (AAA) stent graft and and Hercules low-profile thoracic aortic aneurysm (TAA) stent...
Endologix announces first commercial implant of Alto abdominal stent graft system...
Endologix has announced the first implant of its recently approved Alto endograft outside of the USA, completed by Andrew Holden and Andrew Hill of...
VQI propensity-matched analysis finds endovascular repair of rAAA superior to open...
A recent study examining the effect of operative approach on outcomes in patients presenting with ruptured abdominal aortic aneurysm (rAAA) demonstrated clear short- and...
Five-year survival following EVAR for ruptured AAA “improving,” study concludes
“The relative survival benefit of EVAR over open repair has increased over time,” conclude Rens RB Varkevisser (Beth Israel Deaconess Medical Center, Harvard Medical...
Endologix enters into agreement with Deerfield Partners to take the company...
Endologix has announced that, after evaluating a variety of strategic options, it has initiated a voluntary Chapter 11 case and simultaneously filed a consensual...
Researchers find no benefit for treatment used to avoid surgery for...
A new study by researchers at the University of Maryland School of Medicine (UMSOM; Baltimore, USA) found that patients with an abdominal aortic aneurysm...
Terumo Aortic announces FDA approval for Treo endovascular device
Terumo Aortic has announced that the US Food and Drug Administration (FDA) has granted approval of the Treo abdominal aortic stent-graft system for sale...
“Excellent” long-term results after EVAR using Endurant stent graft in 180...
Results from a real-world experience over more than 10 years using the Endurant stent graft (Medtronic) demonstrate that it is safe and effective, with...
Vascular Society comments on NICE AAA guidelines
On 15 April 2020, the Vascular Society of Great Britain and Ireland (Vascular Society) issued a comment on the recently published UK National Institute...
NICE aortic guidelines recommend discussion between physician and patient before offering...
The UK National Institute for Health and Care Excellence (NICE) has today published guidelines on abdominal aortic aneurysm (AAA) diagnosis and management. Discussion between...
Transabdominal open AAA repair shows higher rate of late reintervention than...
Repair-related reinterventions and readmissions are lower after retroperitoneal compared with transabdominal open abdominal aortic aneurysm (AAA) repair, according to a large multicentre retrospective review...
Trials needed to assess whether metformin impedes aneurysm progression in non-diabetic...
Ronald Dalman (Stanford, USA) and Kak Khee Yeung (Amsterdam, The Netherlands) talk to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA) about how the use of...
VSASM 2019: “Extreme care” needed not to overgeneralise when creating AAA...
Jan Blankensteijn (Amsterdam, Netherlands) talks to BLearning Aortic at VSASM 2019 (Vascular Societies’ Annual Scientific Meeting; 27–29 November, Manchester, UK) following his Kinmonth Lecture presentation titled ‘The current...
US Preventive Services Task Force releases new recommendation on AAA screening
The US Preventive Services Task Force (USPSTF) has released a new recommendation statement on screening for abdominal aortic aneurysms (AAA) in asymptomatic adults 50...
Medtronic presents one-year Valiant Navion, four-year ANCHOR registry clinical outcomes
Medtronic has announced one-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and four-year clinical outcomes from the ANCHOR...
Endologix comments on recent FDA update on Type III endoleaks with...
Endologix have announced a response to the US Food and Drug Administration (FDA) update regarding Type III endoleaks with the AFX Endovascular AAA System.
Matt...
Benefit of EVAR for rAAA will be lost if elective EVAR...
At the first London Aorta meeting, a collaborative association between the London Aorta Masterclass and the London Aortic Symposium, held 10–11 October in London,...
FDA issues update on risk of endoleaks with use of Endologix...
The US Food and Drug Administration (FDA) has issued a new safety communication on the risk of Type III endoleaks with use of the...
ESVS 2019: “Specific need” for improved management in ruptured AAAs in...
Kevin Mani (Uppsala, Sweden) talks to BLearning Aortic at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about a recently published epidemiological analysis of ruptured abdominal aortic...
NICE abdominal aortic aneurysm guideline takes an “unprecedented” turn
Ian Loftus (London, UK), president of the Vascular Society for Great Britain and Ireland, tells BLearning about the most recent developments in the UK’s...
Simulation training decreases mortality from ruptured aortic aneurysm
New research from Finland found dramatic decreases in mortality from ruptured abdominal aortic aneurysms following a series of simulated staff training sessions on how...
Metformin may reduce growth of abdominal aortic aneurysms
Researchers’ hopes that metformin could reduce the growth of abdominal aortic aneurysms (AAA) recently got a substantial boost from a large study, which found...
Mortality from rAAA decreases, but 43% occur in people not qualified...
Even though the number of deaths due to ruptured aortic aneurysms (rAAA) has decreased in the USA by 68% in recent years, a significant...
European vascular community continues to dispute draft NICE AAA guidelines amidst...
At a session dedicated to the draft abdominal aortic aneurysm (AAA) guidelines put forward by the UK’s National Institute of Health and Care Excellence...
INCRAFT AAA Stent Graft System receives FDA approval
Cordis has announced that the US Food and Drug Administration (FDA) has approved its INCRAFT AAA Stent Graft System for use in complex access...
Outcomes of the ANCHOR registry show consistent outcomes for endoanchors at...
Real-world outcomes in patients from the ANCHOR registry at three years show safe and effective performance of the Heli-FX EndoAnchor system (Medtronic) in complex...
Open vs. endovascular aneurysm repair in the 60-year-old man against the...
“The best treatment for a 60-year-old man with an infrarenal abdominal aortic aneurysm that is above the threshold for intervention is arguably surgery based...
First patient in Europe receives implant of Gore Excluder Conformable AAA...
Gore has announced the first European patient implant of the Gore Excluder Conformable AAA Endoprosthesis with Active Control System. This next-generation endovascular aneurysm repair...
NICE draft guideline casts shadow over EVAR for unruptured aneurysms
The UK’s National Institute for Health and Care Excellence (NICE) has issued draft guidance on abdominal aortic aneurysm (AAA) diagnosis and management. The most...
FDA advisory committee votes in favour of INCRAFT for treatment of...
The US Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee has provided a favourable recommendation on the...
Data support targeted screening of first-degree relatives of aneurysm patients as...
A new study suggests that the familial risk of abdominal aortic aneurysm is much higher than previously thought and this excess risk is highest...
Endologix CEO John McDermott steps down
Endologix, a California-based developer and marketer of innovative treatments for aortic disorders, has announced that John McDermott is stepping down as the company’s Chief...
Patient enrolment completed in Endologix’ ELEVATE IDE trial
Endologix, a developer and marketer of treatments for aortic disorders, has announced the completion of enrollment in the ELEVATE (Expanding Patient Applicability with Polymer Sealing...
ENCHANT will evaluate ChEVAR technique with Endurant II/IIs stent graft system
The post-market, non-interventional, multicentre, non-randomised, single-arm study will enroll approximately 150 patients across 25 sites in Europe and Russia, and will evaluate the safety...
F/BEVAR not cost-effective at two years vs. open repair
Fenestrated or branched endovascular aneurysm repair (F/BEVAR) for thoracoabdominal or complex aortic aneurysm patients “is not cost-effective at two years” compared with open repair,...
First patient enrolled in investigational study of the Gore Excluder Conformable...
Gore has announced the first implant of the Gore Excluder Conformable abdominal aortic aneurysms (AAA) endoprosthesis in the USA. The procedure took place on...
Lombard’s Aorfix IntelliFlex LP delivery system launched in Japan
Lombard Medical has announced the full commercial launch in Japan of its new low-profile IntelliFlex LP delivery system for the Aorfix abdominal aortic aneuryism...
Endologix announces positive clinical results from the LEOPARD clinical study
Endologix has announced positive interim results from the LEOPARD (Looking at EVAR outcomes by primary analysis of randomised data) clinical study. LEOPARD is the...
Lombard issues recall of Altura devices with problem in delivery system
On 30 June 2017, Lombard Medical notified the UK Medicines and Health products Regulatory Agency (MHRA) about problems with the Altura stent graft device....
Competence in EVAR techniques
Endovascular aneurysm repair (EVAR) is a highly specialised and potentially complicated procedure requiring knowledge and skills from several cognitive domains. Indeed, EVAR involves several intricate procedural...
Personalising AAA Care With Polymer Sealing (OUS only)
In this supplement: -The clinical and biological advantages of active sac management with EVAS -10 things to know about Ovation -Ovation: Finally an endograft...
Screening women for abdominal aortic aneurysm would yield little benefit and...
First-time data presentation from the SWAN (Screening Women for Abdominal aNeurysms) project was heard at the 2017 Charing Cross Symposium (CX; 25–28 April, London, UK). The...
Endologix announces enrolment of first patients in ELEVATE IDE clinical study
Endologix has announced today that the first patients were treated in the ELEVATE (Expanding patient applicability with polymer sealing Ovation Alto stent graft) investigational...
Mounting evidence supports increasing use of parallel graft endovascular techniques for...
In a 15-year evolution, parallel graft techniques have emerged as part of the effort to rescue or preserve excluded aortic branches in the context...
Global variations in abdominal aortic aneurysm care revealed
Despite homogenous professional society recommendations, significant global variation still exists in the management of abdominal aortic aneurysms, a US study published in Circulation has...
Medtronic Endurant II/IIs granted CE mark for ChEVAR parallel graft technique
Medtronic has received CE mark for its Endurant II/IIs stent graft system to treat abdominal aortic aneurysm patients using a ChEVAR procedure—a parallel graft...
Endologix’ EVAS FORWARD Global Registry finds positive Nellix outcomes at two...
Data from Endologix' Global Registry have found 98% freedom from persistent endoleaks with its Nellix system at two-year follow-up, among other positive results. The...
Enhanced outcomes found for Medtronic Heli-FX EndoAnchor patients with complex aortic...
Medtronic has announced data demonstrating that the company's Heli-FX EndoAnchor system enhances outcomes and durability in patients with complex aortic abdominal aneurysm (AAA) anatomy,...
Covered bridging stents in endovascular aneurysm repair
Over the past two decades, endovascular repair of abdominal aortic aneurysms (EVAR) has gained popularity. However, specified anatomic characteristics are required to achieve durable...
Zenith endograft produces durable repair while long-term survival rates “remain poor”
Endovascular aneurysm repair (EVAR) using the Zenith endograft (Cook Medical) represents durable repair with a low risk of abdominal aortic aneurysm-related death at 14...
First patients treated with Endologix’s Ovation Alto abdominal stent graft system
The first two patients with abdominal aortic aneurysms (AAA) have been treated with Endologix’s Ovation Alto abdominal stent graft system. The patients were treated...
